NCT07034690View on ClinicalTrials.gov

Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 23, 2026

Study Completion Date

June 30, 2027

Conditions
Atherosclerotic Cardiovascular Disease
Interventions
OTHER

Educational Material

Health Education Intervention delivered via clinic visits (every 4 months) and virtual sessions (between each clinic visit)

OTHER

Standard of care

Standard of care

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY